Cathie Wood’s Ark Venture has stakes in top unicorns. The fund has soared but it’s not for the faint of heart.
The Ark boss just made a massive AI bet.
Cathie Wood's ARK sold $2.78M Twist Bioscience, bought Tempus AI & WeRide Jan 26. Full breakdown of ARK Invest's latest AI ...
ARK Invest files with the SEC to launch CoinDesk 20 crypto ETFs, expanding diversified digital asset exposure beyond Bitcoin for investors.
On the selling side, ARK offloaded 135,193 shares of Beam Therapeutics Inc (NASDAQ:BEAM), with a total dollar value of $4,186,927. This sale was distributed between ARKK and ARKG ETFs, suggesting a ...
ARK Invest disclosed on Tuesday that it has added a new position in Velo3D (VELO) to its ARK Autonomous Technology & Robotics ETF (ARKQ), expanding the fund’s exposure as part of its ongoing portfolio ...
In the biotech space, ARK acquired 127,184 shares of CRISPR Therapeutics AG (NASDAQ:CRSP) through its ARKK and ARKG ETFs, ...
ARK Invest sold $5M Beam Therapeutics and bought WeRide, Tempus AI stock Jan 22. See Cathie Wood's complete trading report and portfolio changes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results